Klarna collates $1bn
The instalment finance provider, which counts several corporates as investors, almost tripled its valuation to $31bn in the round.
Vestiaire Collective unpacks $215m
Condé Nast and Kering joined new and returning investors to back a round valuing the fashion item resale platform in excess of $1bn.
Loggi locks up $205m
SoftBank and Microsoft have helped the last-mile delivery service increase its valuation to roughly $2bn in a round led by CapSur Capital.
Iluvatar CoreX caps off $186m series C
China Unicom has helped the Shanghai Electric-backed computer chip developer close a series C round that will fund commercialisation and research and development.
Tenaya Therapeutics takes in $106m
GV returned to help heart disease drug developer Tenaya boost its overall funding to approximately $248m.
Oxular eyes $37m round
Hovione Scientia and Consort Medical-backed Oxular has secured funding that will support phase 2 trials for a treatment for diabetic macular oedema.
Cision to snag Brandwatch in $450m acquisition
Cision, already a shareholder in the social media analytics provider, is set to pay $450m to acquire it, following $63m in funding.
Carisma charms its way to $59m
Penn Medicine contributed to a $12m extension for the cancer immunotherapy developer's series B round, which already inlcuded Livzon, Merck & Co and AbbVie.

News Continued

MDLive heads to Evernorth
Sutter Health, Novo, Sentara and Health Care Service Corporation are set to exit the virtual healthcare provider in an acquisition of undisclosed size.
Armorblox stocks up with $30m
Siemens' Next47 unit led a series B round for the email security platform developer, increasing its total funding to more than $46m.
PharmEasy sells stake to CDPQ
The pension fund will pay an undisclosed sum for a 2% stake in API Holdings, the owner of online drugstore PharmEasy backed by Ascent Health and Medi Assist.
AstraZeneca achieves Moderna stake sale
AstraZeneca likely received over $1bn from selling its shares, having invested $140m in the publicly listed covid-19 vaccine developer in 2015.
Skydio soars with $170m
Siemens’ Next47 subsidiary has returned to back the unmanned aerial vehicle technology producer’s latest round, valuing it above $1bn.
BetterUp bags $125m
Salesforce Ventures helped the professional coaching services provider push its valuation past $1.7bn in its series D round.

Editor's Picks

Klarna collates $1bn
The instalment finance provider, which counts several corporates as investors, almost tripled its valuation to $31bn in the round.
Horizon Robotics prises $350m from investors
Several automotive manufacturers backed a series C3 round taking the AI chip developer's funding to $900m in the past two months.
23andMe links to Virgin in $3.5bn reverse merger
The corporate-backed genetic testing service is joining forces with an NYSE-listed special purpose acquisition company sponsored by Virgin Group.
Sana Bio plants itself on public markets
The Alphabet-backed immunotherapy developer secured nearly $588m in what was reputedly the largest ever flotation for a preclinical life sciences company.
test reg